The company has subscribed 5000 ordinary shares of AED 10 each, aggregating to AED 50,000. The incorporated entity being a wholly owned subsidiary, is a related party of the company.
Morepen Laboratories is a vertically integrated, innovation-led pharmaceutical and healthcare company delivering highquality APIs, branded generics, medical devices, and consumer wellness products to over 80 countries worldwide.
The company’s consolidated net profit declined 28.18% to Rs 20.31 crore despite a 10.11% jump in revenue from operations to Rs 465.85 crore in Q4 FY25 over Q4 FY24.
The counter declined 2.29% to settle at Rs 62.23 on the BSE.
"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."